As a consequence, the depletion of ADAR2 sensitized mesothelioma cells to pemetrexed, a first-line antifolate chemotherapy for mesothelioma (Fig. 5B) (Hariharan et al., 2022). The gene discussed is ADARB1; the disease is mesothelioma.